JLK, Inc. (KOSDAQ:322510)

Market Cap	149.37B
Revenue (ttm)	1.78B
Net Income (ttm)	-12.79B
Shares Out	25.19M
EPS (ttm)	-562.95
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,226
Average Volume	63,743
Open	6,000.00
Previous Close	5,940.00
Day's Range	5,850.00 - 6,020.00
52-Week Range	5,450.00 - 13,700.00
Beta	1.29
RSI	42.05
Earnings Date	Aug 14, 2025

About JLK, Inc.

JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coro...

• Industry: Conglomerates
• Sector: Industrials
• CEO: Dongmin Kim
• Employees: 71
• Stock Exchange: KOSDAQ
• Ticker Symbol: 322510

Financial Performance

In 2024, JLK, Inc.'s revenue was 1.43 billion, a decrease of -42.65% compared to the previous year's 2.49 billion. Losses were -13.45 billion, 83.7% more than in 2023.